BEST SFA Pilot Study - Best Endovascular STrategy for Complex Lesions of the Superficial Femoral Artery

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

Also called NCT03776799

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03776799
Other papers using this trial's data
  • Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions JACC. Cardiovascular interventions, 2024-05-13 DOI, PubMed 38749594

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03776799. Randomized; no masking; primary purpose treatment. Start 2019-01-01 (actual); primary completion 2022-08-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BEST SFA Pilot Study - Best Endovascular STrategy for Complex Lesions of the Superficial Femoral Artery
Condition
Peripheral Arterial Disease
Intervention (Device)
Stent-avoiding
Intervention (Device)
Stent-based
Lead sponsor
University of Leipzig (class: other)

Record details

Record id
cardio:ct-nct03776799
Content hash
38b788f792d927dc409b9edc5924bc31e7152be6d9d7d1e164e1829c9324dc1a